Serum Institute Clarifies About Availability of Corona Vaccine in 73 Days

Share this News:

Pune, August 23, 2020: Serum Institute of India has come out with an important statement regarding the introduction of Corona vaccine within 73 days in India. The company has stated COVISHIELD will be launched in the market only when there is a complete success in the trials and regulatory approvals are obtained.

“Serum Institute of India would like to clarify that the current claims surrounding COVISHIELD’s availability in the media are completely false and conjectural. Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use. COVISHIELD will be commercialized once the trials are proven successful and all the requisite regulatory approvals are in place. The phase-3 trials for the Oxford-AstraZeneca vaccine are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially”, SII issued a statement.

Some media reports had said that the COVISHIELD vaccine of Serum Institute of India will be available in the markets within 73 days. Now the company has clearly stated that it is just speculation. The vaccine will be brought to market only when all its trials are successful and COVISHIELD will receive regulatory approval.